s1 episode 2: biomarkers and targeted therapies for lung cancer
Published 3 months ago • 50 plays • Length 23:52Download video MP4
Download video MP3
Similar videos
-
22:41
s1 episode 5: small cell lung cancer: what are the first-line and second-line treatment options?
-
5:53
targeted therapy in non-small cell lung cancer
-
3:32
understanding non-small cell lung cancer: types, biomarkers, and treatment insights
-
1:09:51
lung cancer biomarkers & targeted therapies - webinar
-
5:06
కీమో థెరపీ కంటే 100 రెట్ల పవర్ ఉన్న న్యాచురల్ టిప్ | cancer tips | dr manthena satyanarayana raju
-
4:09
the pathophysiology of non-small cell lung cancer
-
3:46
understanding immunotherapy for lung cancer
-
15:26
stage 2 lung adenocarcinoma: biomarkers & treatment approaches - case-based panel discussions
-
3:35
what are biomarkers and how do they impact lung cancer treatment options?
-
6:14
understanding biomarker testing in non-small cell lung cancer
-
1:31:34
tailoring targeted therapy: new directions for managing patients across the spectrum of nsclc
-
1:37
what is targeted therapy for lung cancer?
-
3:33
what is ‘comprehensive biomarker testing’ and why is it important in lung cancer?
-
17:20
lung cancer (part 2) 2021
-
3:15
how does biomarker testing impact non-small cell lung cancer care?
-
2:09
biomarker targeted therapy for lung cancer
-
33:52
keynote lecture: targeted therapies in lung cancer 2.0 – advances and promises
-
10:28
candid conversations in lung cancer: discussing biomarker testing and targeted therapies
-
1:50
lung cancer and biomarker testing: two families’ stories
-
0:37
which lung cancer mutations have approved targeted therapies?
-
6:27
standard of care therapy in lung cancer be open to new ideas